Andon Health Co., Ltd. (002432.SZ)
CNY 42.22
(-0.31%)
CNY 42.22
(-0.31%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 282.89 Million CNY | -59.45% |
| 2022 | 697.61 Million CNY | 11.12% |
| 2021 | 627.81 Million CNY | 123.22% |
| 2020 | 281.26 Million CNY | 42.99% |
| 2019 | 196.7 Million CNY | -17.8% |
| 2018 | 239.29 Million CNY | 17.4% |
| 2017 | 203.81 Million CNY | -12.96% |
| 2016 | 234.15 Million CNY | -13.38% |
| 2015 | 270.34 Million CNY | -0.86% |
| 2014 | 272.67 Million CNY | 33.42% |
| 2013 | 204.38 Million CNY | 56.35% |
| 2012 | 130.71 Million CNY | -2.59% |
| 2011 | 134.19 Million CNY | 71.34% |
| 2010 | 78.32 Million CNY | 74.73% |
| 2009 | 44.82 Million CNY | -22.95% |
| 2008 | 58.17 Million CNY | 49.17% |
| 2007 | 39 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 217.64 Million CNY | 2.76% |
| 2024 Q2 | 211.8 Million CNY | -7.65% |
| 2024 Q1 | 229.34 Million CNY | -18.93% |
| 2023 Q4 | 282.89 Million CNY | 4.54% |
| 2023 Q1 | 501.66 Million CNY | -28.09% |
| 2023 Q2 | 261.54 Million CNY | -47.86% |
| 2023 FY | 282.89 Million CNY | -59.45% |
| 2023 Q3 | 270.59 Million CNY | 3.46% |
| 2022 FY | 697.61 Million CNY | 11.12% |
| 2022 Q1 | 1.19 Billion CNY | 90.07% |
| 2022 Q4 | 697.61 Million CNY | -42.94% |
| 2022 Q2 | 1.15 Billion CNY | -2.79% |
| 2022 Q3 | 1.22 Billion CNY | 5.4% |
| 2021 Q2 | 265.44 Million CNY | 2.87% |
| 2021 FY | 627.81 Million CNY | 123.22% |
| 2021 Q3 | 297.95 Million CNY | 12.25% |
| 2021 Q4 | 627.81 Million CNY | 110.71% |
| 2021 Q1 | 258.03 Million CNY | -8.26% |
| 2020 Q3 | 310.98 Million CNY | -4.03% |
| 2020 FY | 281.26 Million CNY | 42.99% |
| 2020 Q1 | 177.93 Million CNY | -9.54% |
| 2020 Q2 | 324.03 Million CNY | 82.11% |
| 2020 Q4 | 281.26 Million CNY | -9.56% |
| 2019 Q1 | 221.12 Million CNY | -7.59% |
| 2019 FY | 196.7 Million CNY | -17.8% |
| 2019 Q4 | 196.7 Million CNY | -16.4% |
| 2019 Q3 | 235.28 Million CNY | -3.2% |
| 2019 Q2 | 243.07 Million CNY | 9.93% |
| 2018 Q2 | 223.89 Million CNY | 6.09% |
| 2018 FY | 239.29 Million CNY | 17.4% |
| 2018 Q4 | 239.29 Million CNY | -3.47% |
| 2018 Q3 | 247.9 Million CNY | 10.72% |
| 2018 Q1 | 211.04 Million CNY | 3.55% |
| 2017 Q3 | 224.61 Million CNY | -2.78% |
| 2017 FY | 203.81 Million CNY | -12.96% |
| 2017 Q2 | 231.03 Million CNY | -6.27% |
| 2017 Q4 | 203.81 Million CNY | -9.26% |
| 2017 Q1 | 246.48 Million CNY | 5.27% |
| 2016 Q3 | 256.18 Million CNY | -11.76% |
| 2016 FY | 234.15 Million CNY | -13.38% |
| 2016 Q1 | 275.86 Million CNY | 2.05% |
| 2016 Q4 | 234.15 Million CNY | -8.6% |
| 2016 Q2 | 290.32 Million CNY | 5.24% |
| 2015 FY | 270.34 Million CNY | -0.86% |
| 2015 Q4 | 270.34 Million CNY | -4.42% |
| 2015 Q1 | 257.7 Million CNY | -5.49% |
| 2015 Q2 | 277.51 Million CNY | 7.69% |
| 2015 Q3 | 282.84 Million CNY | 1.92% |
| 2014 FY | 272.67 Million CNY | 33.42% |
| 2014 Q4 | 272.67 Million CNY | 10.91% |
| 2014 Q1 | 196.23 Million CNY | -3.99% |
| 2014 Q3 | 245.86 Million CNY | 10.02% |
| 2014 Q2 | 223.47 Million CNY | 13.88% |
| 2013 Q2 | 165.01 Million CNY | 22.03% |
| 2013 Q4 | 204.38 Million CNY | 7.64% |
| 2013 FY | 204.38 Million CNY | 56.35% |
| 2013 Q1 | 135.22 Million CNY | 3.45% |
| 2013 Q3 | 189.88 Million CNY | 15.07% |
| 2012 Q4 | 130.71 Million CNY | -11.7% |
| 2012 FY | 130.71 Million CNY | -2.59% |
| 2012 Q2 | 123.16 Million CNY | 1.62% |
| 2012 Q1 | 121.2 Million CNY | -9.68% |
| 2012 Q3 | 148.04 Million CNY | 20.2% |
| 2011 Q4 | 134.19 Million CNY | -9.24% |
| 2011 Q3 | 147.85 Million CNY | 36.21% |
| 2011 Q2 | 108.54 Million CNY | 23.58% |
| 2011 Q1 | 87.83 Million CNY | 12.15% |
| 2011 FY | 134.19 Million CNY | 71.34% |
| 2010 Q1 | 57.31 Million CNY | 27.87% |
| 2010 Q2 | 62.52 Million CNY | 9.09% |
| 2010 Q3 | 75.96 Million CNY | 21.49% |
| 2010 FY | 78.32 Million CNY | 74.73% |
| 2010 Q4 | 78.32 Million CNY | 3.1% |
| 2009 FY | 44.82 Million CNY | -22.95% |
| 2009 Q4 | 44.82 Million CNY | 0.0% |
| 2008 FY | 58.17 Million CNY | 49.17% |
| 2007 FY | 39 Million CNY | 0.0% |